5-OXOPIPERIDINE-2-CARBOXYLIC ACID HCL, 95.0%, 250mg

tert-Butyl (pyrrolidin-2-ylmethyl)carbamate hydrochloride, 97%, 100mg

Pomalidomide-PEG2-COOH, 50mg

Acetona Mín. 99,5 % para envases de vidrio de síntesis Envases de vidrio de 2,5 l

(S)-2-(3-Fluorophenyl)pyrrolidine d-tartrate, 97.0%, 10g

(R)-2-Amino-2-cyclopentylacetic acid, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-2-yl)propanoic acid, 95.0%, 250mg

4-(4-Methylpiperidin-4-yl)morpholinedihydrochloride, 95.0%, 250mg

4-(Trifluoromethyl)piperidine, 97.0%, 250mg

1-(2-Furoyl)piperazine Hydrochloride>98.0%(HPLC)(N)5g

3-Bromo-1-ethyl-1H-pyrazole, 97.0%, 50mg

Homopiperazine, 97.0%, 500g

3',5'-dimethoxy-5-(5,5-dimethyl-1,3-dioxan-2-yl)valerophenone, 97.0%, 1g